UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043155
Receipt number R000049141
Scientific Title Exploratory research for blood markers associated with clinical symptoms of psychiatric disorders
Date of disclosure of the study information 2021/01/27
Last modified on 2023/01/30 15:46:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory research for blood markers associated with clinical symptoms of psychiatric disorders

Acronym

Exploratory research for blood markers of psychiatric disorders

Scientific Title

Exploratory research for blood markers associated with clinical symptoms of psychiatric disorders

Scientific Title:Acronym

Exploratory research for blood markers of psychiatric disorders

Region

Japan


Condition

Condition

Depressive Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Bipolar and Related Disorders
Anxiety Disorders

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Search for blood markers associated with clinical symptoms of psychiatric disorders

Basic objectives2

Others

Basic objectives -Others

Correlation among blood markers and symptom rating scales for psychiatric disorders

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Correlation among nardilysin and symptom rating scales for psychiatric disorders

Key secondary outcomes

Correlation among time-course changes of blood markers and those of symptom rating scales for psychiatric disorders


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Those who have any of the following diseases: Depressive Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Bipolar and Related Disorders, and Anxiety Disorders
People who can understand the explanatory document of the research and can obtain written consent.

Key exclusion criteria

Patients who are considered unsuitable as research subjects by the principal investigator or sub-investigator
Patients with severe anemia (hemoglobin less than 6 g/dL, etc.)

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Ozeki
Middle name
Last name Yuji

Organization

Shiga University of Medical Science

Division name

Department of Psychiatry

Zip code

520-2192

Address

Seta Tsukinowa-cho, Otsu, Shiga

TEL

+81-77-548-2291

Email

ozeki@belle.shiga-med.ac.jp


Public contact

Name of contact person

1st name Sumi
Middle name
Last name Yukiyoshi

Organization

Shiga University of Medical Science

Division name

Department of Psychiatry

Zip code

520-2192

Address

Seta Tsukinowa-cho, Otsu, Shiga

TEL

+81-77-548-2291

Homepage URL


Email

ysumi@belle.shiga-med.ac.jp


Sponsor or person

Institute

Shiga University of Medical Science

Institute

Department

Personal name



Funding Source

Organization

Shiga University of Medical Science
Scholarship donations from Sanyo Chemical Industries, Ltd.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiga University of Medical Science Research Ethics Committee

Address

Seta Tsukinowa-cho, Otsu, Shiga

Tel

+81-77-548-3576

Email

hqrec@belle.shiga-med.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

R2020-141

Org. issuing International ID_1

Shiga University of Medical Science Research Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

滋賀医科大学病院(滋賀県)


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 11 Month 10 Day

Date of IRB

2020 Year 11 Month 25 Day

Anticipated trial start date

2021 Year 01 Month 20 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is an observational study.
It may lead to the development of objective biomarkers for psychiatric disorders.


Management information

Registered date

2021 Year 01 Month 27 Day

Last modified on

2023 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049141


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name